Bionoid Pharma Inc (BINP)
0.20
0.00 (0.00%)
USD |
OTCM |
Jun 20, 16:00
Bionoid Pharma Max Drawdown (5Y): 99.87% for May 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| May 31, 2024 | 99.87% |
| April 30, 2024 | 99.87% |
| March 31, 2024 | 99.87% |
| February 29, 2024 | 99.87% |
| January 31, 2024 | 99.87% |
| December 31, 2023 | 99.87% |
| November 30, 2023 | 99.87% |
| October 31, 2023 | 99.87% |
| September 30, 2023 | 99.87% |
| August 31, 2023 | 99.87% |
| July 31, 2023 | 99.87% |
| June 30, 2023 | 99.87% |
| May 31, 2023 | 99.87% |
| April 30, 2023 | 99.87% |
| March 31, 2023 | 99.01% |
| February 28, 2023 | 99.01% |
| January 31, 2023 | 99.01% |
| December 31, 2022 | 99.01% |
| November 30, 2022 | 99.01% |
| October 31, 2022 | 99.01% |
| September 30, 2022 | 99.01% |
| August 31, 2022 | 99.01% |
| July 31, 2022 | 99.01% |
| June 30, 2022 | 99.01% |
| May 31, 2022 | 99.01% |
| Date | Value |
|---|---|
| April 30, 2022 | 99.01% |
| March 31, 2022 | 99.01% |
| February 28, 2022 | 99.01% |
| January 31, 2022 | 99.01% |
| December 31, 2021 | 99.01% |
| November 30, 2021 | 98.50% |
| October 31, 2021 | 98.50% |
| September 30, 2021 | 98.70% |
| August 31, 2021 | 98.70% |
| July 31, 2021 | 98.70% |
| June 30, 2021 | 98.70% |
| May 31, 2021 | 98.70% |
| April 30, 2021 | 98.70% |
| March 31, 2021 | 98.70% |
| February 28, 2021 | 98.70% |
| January 31, 2021 | 98.70% |
| December 31, 2020 | 98.70% |
| November 30, 2020 | 98.70% |
| October 31, 2020 | 98.75% |
| September 30, 2020 | 99.20% |
| August 31, 2020 | 99.23% |
| July 31, 2020 | 99.23% |
| June 30, 2020 | 99.23% |
| May 31, 2020 | 99.23% |
| April 30, 2020 | 99.23% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
98.50%
Minimum
Oct 2021
99.87%
Maximum
Apr 2023
99.19%
Average
99.11%
Median
Max Drawdown (5Y) Benchmarks
| Cotinga Pharmaceuticals Inc | 100.00% |
| Acasti Pharma Inc | 98.73% |
| Aurinia Pharmaceuticals Inc | 87.58% |
| Edesa Biotech Inc | 99.58% |
| Lexaria Bioscience Corp | 98.90% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -10.30 |
| Beta (5Y) | -3.291 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 489.9% |
| Historical Sharpe Ratio (5Y) | -0.1131 |
| Historical Sortino (5Y) | -0.7453 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 55.56% |